Cardioprotective effect of MCC-135 is associated with inhibition of Ca2+ overload in ischemic/reperfused hearts

This publication has 34 references indexed in Scilit:

• Effect of inhibition of Na+/Ca2+ exchanger at the time of myocardial reperfusion on hypercontracture and cell death
  Cardiovascular Research, 2002
• Inhibition of Na⁺/Ca²⁺ exchange by KB-R7943: transport mode selectivity and antiarrhythmic consequences
  American Journal of Physiology-Heart and Circulatory Physiology, 2001
• Anti-Ischemic Effect of a Novel Cardioprotective Agent, JTV519, Is Mediated Through Specific Activation of δ-Isoform of Protein Kinase C in Rat Ventricular Myocardium
  Circulation, 2000
• Mechanisms of postischemic contractile dysfunction
  The Annals of Thoracic Surgery, 1999
• Restoration of impaired sr Ca2+ — ATPase activity by MCC-135 is associated with the improvement of depressed contractile function in canine postischemic myocardium
  Journal of Cardiac Failure, 1999
• Rational basis for use of sodium–hydrogen exchange inhibitors in myocardial ischemia
  The American Journal of Cardiology, 1999
• Molecular and Cellular Mechanisms of Myocardial Stunning
  Physiological Reviews, 1999
• MCC-135, a new agent for the treatment of heart diseases
  The Japanese Journal of Pharmacology, 1998
• Myocardial reperfusion: a double-edged sword?
  Journal of Clinical Investigation, 1985
• The change of the free energy of ATP hydrolysis during global ischemia and anoxia in the rat heartIts possible role in the regulation of transsarcolemmal sodium and potassium gradients
  Journal of Molecular and Cellular Cardiology, 1984